Global Nanomedicine Market Research Report 2023

Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.

The global Nanomedicine market was valued at US$ 170.1 million in 2022 and is anticipated to reach US$ 246.8 million by 2029, witnessing a CAGR of 6.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

As per the WHO factsheet, cancer is found to be one of the major causes of mortality and morbidity worldwide, with approximately 14 million new cases in 2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in order to curb such high incidence rate is expected to boost market progress during the forecast period.

This report aims to provide a comprehensive presentation of the global market for Nanomedicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanomedicine.

The Nanomedicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nanomedicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanomedicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Quantum dots

1.2.3 Nanoparticles

1.2.4 Nanoshells

1.2.5 Nanotubes

1.2.6 Nanodevices

1.3 Market by Application

1.3.1 Global Nanomedicine Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 oncology

1.3.3 Infectious diseases

1.3.4 Cardiology

1.3.5 Orthopedics

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Nanomedicine Market Perspective (2018-2029)

2.2 Nanomedicine Growth Trends by Region

2.2.1 Global Nanomedicine Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Nanomedicine Historic Market Size by Region (2018-2023)

2.2.3 Nanomedicine Forecasted Market Size by Region (2024-2029)

2.3 Nanomedicine Market Dynamics

2.3.1 Nanomedicine Industry Trends

2.3.2 Nanomedicine Market Drivers

2.3.3 Nanomedicine Market Challenges

2.3.4 Nanomedicine Market Restraints

3.1 Global Top Nanomedicine Players by Revenue

3.1.1 Global Top Nanomedicine Players by Revenue (2018-2023)

3.1.2 Global Nanomedicine Revenue Market Share by Players (2018-2023)

3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Nanomedicine Revenue

3.4 Global Nanomedicine Market Concentration Ratio

3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2022

3.5 Nanomedicine Key Players Head office and Area Served

3.6 Key Players Nanomedicine Product Solution and Service

3.7 Date of Enter into Nanomedicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Nanomedicine Historic Market Size by Type (2018-2023)

4.2 Global Nanomedicine Forecasted Market Size by Type (2024-2029)

5.1 Global Nanomedicine Historic Market Size by Application (2018-2023)

5.2 Global Nanomedicine Forecasted Market Size by Application (2024-2029)

6.1 North America Nanomedicine Market Size (2018-2029)

6.2 North America Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Nanomedicine Market Size by Country (2018-2023)

6.4 North America Nanomedicine Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Nanomedicine Market Size (2018-2029)

7.2 Europe Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Nanomedicine Market Size by Country (2018-2023)

7.4 Europe Nanomedicine Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Nanomedicine Market Size (2018-2029)

8.2 Asia-Pacific Nanomedicine Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Nanomedicine Market Size by Region (2018-2023)

8.4 Asia-Pacific Nanomedicine Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Nanomedicine Market Size (2018-2029)

9.2 Latin America Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Nanomedicine Market Size by Country (2018-2023)

9.4 Latin America Nanomedicine Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Nanomedicine Market Size (2018-2029)

10.2 Middle East & Africa Nanomedicine Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Nanomedicine Market Size by Country (2018-2023)

10.4 Middle East & Africa Nanomedicine Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Combimatrix

11.1.1 Combimatrix Company Detail

11.1.2 Combimatrix Business Overview

11.1.3 Combimatrix Nanomedicine Introduction

11.1.4 Combimatrix Revenue in Nanomedicine Business (2018-2023)

11.1.5 Combimatrix Recent Development

11.2 Ablynx

11.2.1 Ablynx Company Detail

11.2.2 Ablynx Business Overview

11.2.3 Ablynx Nanomedicine Introduction

11.2.4 Ablynx Revenue in Nanomedicine Business (2018-2023)

11.2.5 Ablynx Recent Development

11.3 Abraxis Bioscience

11.3.1 Abraxis Bioscience Company Detail

11.3.2 Abraxis Bioscience Business Overview

11.3.3 Abraxis Bioscience Nanomedicine Introduction

11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2018-2023)

11.3.5 Abraxis Bioscience Recent Development

11.4 Celgene

11.4.1 Celgene Company Detail

11.4.2 Celgene Business Overview

11.4.3 Celgene Nanomedicine Introduction

11.4.4 Celgene Revenue in Nanomedicine Business (2018-2023)

11.4.5 Celgene Recent Development

11.5 Mallinckrodt

11.5.1 Mallinckrodt Company Detail

11.5.2 Mallinckrodt Business Overview

11.5.3 Mallinckrodt Nanomedicine Introduction

11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2018-2023)

11.5.5 Mallinckrodt Recent Development

11.6 Arrowhead Research

11.6.1 Arrowhead Research Company Detail

11.6.2 Arrowhead Research Business Overview

11.6.3 Arrowhead Research Nanomedicine Introduction

11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2018-2023)

11.6.5 Arrowhead Research Recent Development

11.7 GE Healthcare

11.7.1 GE Healthcare Company Detail

11.7.2 GE Healthcare Business Overview

11.7.3 GE Healthcare Nanomedicine Introduction

11.7.4 GE Healthcare Revenue in Nanomedicine Business (2018-2023)

11.7.5 GE Healthcare Recent Development

11.8 Merck

11.8.1 Merck Company Detail

11.8.2 Merck Business Overview

11.8.3 Merck Nanomedicine Introduction

11.8.4 Merck Revenue in Nanomedicine Business (2018-2023)

11.8.5 Merck Recent Development

11.9 Pfizer

11.9.1 Pfizer Company Detail

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Nanomedicine Introduction

11.9.4 Pfizer Revenue in Nanomedicine Business (2018-2023)

11.9.5 Pfizer Recent Development

11.10 Nanosphere

11.10.1 Nanosphere Company Detail

11.10.2 Nanosphere Business Overview

11.10.3 Nanosphere Nanomedicine Introduction

11.10.4 Nanosphere Revenue in Nanomedicine Business (2018-2023)

11.10.5 Nanosphere Recent Development

11.11 Epeius Biotechnologies

11.11.1 Epeius Biotechnologies Company Detail

11.11.2 Epeius Biotechnologies Business Overview

11.11.3 Epeius Biotechnologies Nanomedicine Introduction

11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2018-2023)

11.11.5 Epeius Biotechnologies Recent Development

11.12 Cytimmune Sciences

11.12.1 Cytimmune Sciences Company Detail

11.12.2 Cytimmune Sciences Business Overview

11.12.3 Cytimmune Sciences Nanomedicine Introduction

11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2018-2023)

11.12.5 Cytimmune Sciences Recent Development

11.13 Nanospectra Biosciences

11.13.1 Nanospectra Biosciences Company Detail

11.13.2 Nanospectra Biosciences Business Overview

11.13.3 Nanospectra Biosciences Nanomedicine Introduction

11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2018-2023)

11.13.5 Nanospectra Biosciences Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Quantum dots

    Table 3. Key Players of Nanoparticles

    Table 4. Key Players of Nanoshells

    Table 5. Key Players of Nanotubes

    Table 6. Key Players of Nanodevices

    Table 7. Global Nanomedicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Nanomedicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Nanomedicine Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Nanomedicine Market Share by Region (2018-2023)

    Table 11. Global Nanomedicine Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Nanomedicine Market Share by Region (2024-2029)

    Table 13. Nanomedicine Market Trends

    Table 14. Nanomedicine Market Drivers

    Table 15. Nanomedicine Market Challenges

    Table 16. Nanomedicine Market Restraints

    Table 17. Global Nanomedicine Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Nanomedicine Market Share by Players (2018-2023)

    Table 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2022)

    Table 20. Ranking of Global Top Nanomedicine Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Nanomedicine Product Solution and Service

    Table 24. Date of Enter into Nanomedicine Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Nanomedicine Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Nanomedicine Revenue Market Share by Type (2018-2023)

    Table 28. Global Nanomedicine Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Nanomedicine Revenue Market Share by Type (2024-2029)

    Table 30. Global Nanomedicine Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Nanomedicine Revenue Market Share by Application (2018-2023)

    Table 32. Global Nanomedicine Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Nanomedicine Revenue Market Share by Application (2024-2029)

    Table 34. North America Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Nanomedicine Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Nanomedicine Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Nanomedicine Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Nanomedicine Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Nanomedicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Nanomedicine Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Nanomedicine Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Nanomedicine Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Nanomedicine Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Nanomedicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Nanomedicine Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Nanomedicine Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Combimatrix Company Detail

    Table 50. Combimatrix Business Overview

    Table 51. Combimatrix Nanomedicine Product

    Table 52. Combimatrix Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 53. Combimatrix Recent Development

    Table 54. Ablynx Company Detail

    Table 55. Ablynx Business Overview

    Table 56. Ablynx Nanomedicine Product

    Table 57. Ablynx Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 58. Ablynx Recent Development

    Table 59. Abraxis Bioscience Company Detail

    Table 60. Abraxis Bioscience Business Overview

    Table 61. Abraxis Bioscience Nanomedicine Product

    Table 62. Abraxis Bioscience Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 63. Abraxis Bioscience Recent Development

    Table 64. Celgene Company Detail

    Table 65. Celgene Business Overview

    Table 66. Celgene Nanomedicine Product

    Table 67. Celgene Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 68. Celgene Recent Development

    Table 69. Mallinckrodt Company Detail

    Table 70. Mallinckrodt Business Overview

    Table 71. Mallinckrodt Nanomedicine Product

    Table 72. Mallinckrodt Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 73. Mallinckrodt Recent Development

    Table 74. Arrowhead Research Company Detail

    Table 75. Arrowhead Research Business Overview

    Table 76. Arrowhead Research Nanomedicine Product

    Table 77. Arrowhead Research Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 78. Arrowhead Research Recent Development

    Table 79. GE Healthcare Company Detail

    Table 80. GE Healthcare Business Overview

    Table 81. GE Healthcare Nanomedicine Product

    Table 82. GE Healthcare Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 83. GE Healthcare Recent Development

    Table 84. Merck Company Detail

    Table 85. Merck Business Overview

    Table 86. Merck Nanomedicine Product

    Table 87. Merck Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 88. Merck Recent Development

    Table 89. Pfizer Company Detail

    Table 90. Pfizer Business Overview

    Table 91. Pfizer Nanomedicine Product

    Table 92. Pfizer Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 93. Pfizer Recent Development

    Table 94. Nanosphere Company Detail

    Table 95. Nanosphere Business Overview

    Table 96. Nanosphere Nanomedicine Product

    Table 97. Nanosphere Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 98. Nanosphere Recent Development

    Table 99. Epeius Biotechnologies Company Detail

    Table 100. Epeius Biotechnologies Business Overview

    Table 101. Epeius Biotechnologies Nanomedicine Product

    Table 102. Epeius Biotechnologies Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 103. Epeius Biotechnologies Recent Development

    Table 104. Cytimmune Sciences Company Detail

    Table 105. Cytimmune Sciences Business Overview

    Table 106. Cytimmune Sciences Nanomedicine Product

    Table 107. Cytimmune Sciences Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 108. Cytimmune Sciences Recent Development

    Table 109. Nanospectra Biosciences Company Detail

    Table 110. Nanospectra Biosciences Business Overview

    Table 111. Nanospectra Biosciences Nanomedicine Product

    Table 112. Nanospectra Biosciences Revenue in Nanomedicine Business (2018-2023) & (US$ Million)

    Table 113. Nanospectra Biosciences Recent Development

    Table 114. Research Programs/Design for This Report

    Table 115. Key Data Information from Secondary Sources

    Table 116. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Nanomedicine Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Nanomedicine Market Share by Type: 2022 VS 2029

    Figure 3. Quantum dots Features

    Figure 4. Nanoparticles Features

    Figure 5. Nanoshells Features

    Figure 6. Nanotubes Features

    Figure 7. Nanodevices Features

    Figure 8. Global Nanomedicine Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Nanomedicine Market Share by Application: 2022 VS 2029

    Figure 10. oncology Case Studies

    Figure 11. Infectious diseases Case Studies

    Figure 12. Cardiology Case Studies

    Figure 13. Orthopedics Case Studies

    Figure 14. Others Case Studies

    Figure 15. Nanomedicine Report Years Considered

    Figure 16. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Nanomedicine Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Nanomedicine Market Share by Region: 2022 VS 2029

    Figure 19. Global Nanomedicine Market Share by Players in 2022

    Figure 20. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2022

    Figure 22. North America Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Nanomedicine Market Share by Country (2018-2029)

    Figure 24. United States Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Nanomedicine Market Share by Country (2018-2029)

    Figure 28. Germany Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Nanomedicine Market Share by Region (2018-2029)

    Figure 36. China Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Nanomedicine Market Share by Country (2018-2029)

    Figure 44. Mexico Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Nanomedicine Market Share by Country (2018-2029)

    Figure 48. Turkey Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Nanomedicine Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Combimatrix Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 51. Ablynx Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 52. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 53. Celgene Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 54. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 55. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 56. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 57. Merck Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 58. Pfizer Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 59. Nanosphere Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 60. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 61. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 62. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2018-2023)

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed